Skip to main content
SpringerLink
Log in

Diagnosing Thrombocytopenia in the Clinic

  • Chapter
  • First Online:
The Coagulation Consult

  • 2045 Accesses

Abstract

With blood work being routinely done for multiple reasons many patients present in clinic with thrombocytopenia. Clinicians should be aware of when to refer patients to hematologists, when patients need immediate admission, and how to work up different causes of thrombocytopenia. This chapter helps clinicians understand when to hospitalize patients with thrombocytopenia, how to establish a diagnosis, and the different causes of thrombocytopenia. Flow charts are provided for a reference on how to work up thrombocytopenia in different situations.

This is a preview of subscription content, log in via an institution to check access.

Access this chapter

Log in via an institution
Chapter
USD 29.95
Price excludes VAT (USA)
  • Available as PDF
  • Read on any device
  • Instant download
  • Own it forever
eBook
USD 119.00
Price excludes VAT (USA)
  • Available as EPUB and PDF
  • Read on any device
  • Instant download
  • Own it forever
Softcover Book
USD 159.99
Price excludes VAT (USA)
  • Compact, lightweight edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info
Hardcover Book
USD 179.99
Price excludes VAT (USA)
  • Durable hardcover edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info

Tax calculation will be finalised at checkout

Purchases are for personal use only

Institutional subscriptions

References

  • Achterbergh R, Vermeer HJ, et al. Thrombocytopenia in a nutshell. Lancet. 2012;379(9817):776.

    Article  PubMed  Google Scholar 

  • Afdhal N, McHutchison J, et al. Thrombocytopenia associated with chronic liver disease. J Hepatol. 2008;48(6):1000–7.

    Article  CAS  PubMed  Google Scholar 

  • Arepally GM, Ortel TL. Clinical practice. Heparin-induced thrombocytopenia. N Engl J Med. 2006;355(8):809–17.

    Article  CAS  PubMed  Google Scholar 

  • Baroletti S, Piovella C, et al. Heparin-induced thrombocytopenia (HIT): clinical and economic outcomes. Thromb Haemost. 2008;100(6):1130–5.

    CAS  PubMed  Google Scholar 

  • Baron JM, Baron BW. Thrombotic thrombocytopenic purpura and its look-alikes. Clin Adv Hematol Oncol. 2005;3(11):868–74.

    PubMed  Google Scholar 

  • Bizzaro N. EDTA-dependent pseudothrombocytopenia: a clinical and epidemiological study of 112 cases, with 10-year follow-up. Am J Hematol. 1995;50(2):103–9.

    Article  CAS  PubMed  Google Scholar 

  • Buckley MF, James JW, et al. A novel approach to the assessment of variations in the human platelet count. Thromb Haemost. 2000;83(3):480–4.

    CAS  PubMed  Google Scholar 

  • Cines DB, Blanchette VS. Immune thrombocytopenic purpura. N Engl J Med. 2002;346(13):995–1008.

    Article  PubMed  Google Scholar 

  • Cines DB, Bussel JB. How I treat idiopathic thrombocytopenic purpura (ITP). Blood. 2005;106(7):2244–51.

    Article  CAS  PubMed  Google Scholar 

  • Cowan DH. Effect of alcoholism on hemostasis. Semin Hematol. 1980;17(2):137–47.

    CAS  PubMed  Google Scholar 

  • Franchini M, Veneri D. Helicobacter pylori-associated immune thrombocytopenia. Platelets. 2006;17(2):71–7.

    Article  CAS  PubMed  Google Scholar 

  • Froom P, Barak M. Prevalence and course of pseudothrombocytopenia in outpatients. Clin Chem Lab Med. 2011;49(1):111–4.

    Article  CAS  PubMed  Google Scholar 

  • Gauer RL, Braun MM. Thrombocytopenia. Am Fam Physician. 2012;85(6):612–22.

    PubMed  Google Scholar 

  • George JN. The thrombotic thrombocytopenic purpura and hemolytic uremic syndromes: evaluation, management, and long-term outcomes experience of the Oklahoma TTP-HUS Registry, 1989–2007. Kidney Int Suppl. 2009;112:S52–4.

    Article  PubMed  Google Scholar 

  • George JN. How I, treat patients with thrombotic thrombocytopenic purpura: 2010. Blood. 2010;116(20):4060–9.

    Article  CAS  PubMed  Google Scholar 

  • George JN, Aster RH. Drug-induced thrombocytopenia: pathogenesis, evaluation, and management. Hematology Am Soc Hematol Educ Program. 2009;153–8.

    Google Scholar 

  • George JN, Woodson RD, et al. Rituximab therapy for thrombotic thrombocytopenic purpura: a proposed study of the Transfusion Medicine/Hemostasis Clinical Trials Network with a systematic review of rituximab therapy for immune-mediated disorders. J Clin Apher. 2006;21(1):49–56.

    Article  PubMed  Google Scholar 

  • George JN, Kremer Hovinga JA, et al. The Oklahoma Thrombotic Thrombocytopenic Purpura-Hemolytic Uremic Syndrome Registry: the Swiss connection. Eur J Haematol. 2008;80(4):277–86.

    Article  PubMed  Google Scholar 

  • Greinacher A, Farner B, et al. Clinical features of heparin-induced thrombocytopenia including risk factors for thrombosis. A retrospective analysis of 408 patients. Thromb Haemost. 2005;94(1):132–5.

    CAS  PubMed  Google Scholar 

  • Hosler GA, Cusumano AM, et al. Thrombotic thrombocytopenic purpura and hemolytic uremic syndrome are distinct pathologic entities. A review of 56 autopsy cases. Arch Pathol Lab Med. 2003;127(7):834–9.

    PubMed  Google Scholar 

  • Kadir RA, McLintock C. Thrombocytopenia and disorders of platelet function in pregnancy. Semin Thromb Hemost. 2011;37(6):640–52.

    Article  PubMed  Google Scholar 

  • Krause I, Blank M, et al. The association of thrombocytopenia with systemic manifestations in the antiphospholipid syndrome. Immunobiology. 2005;210(10):749–54.

    Article  CAS  PubMed  Google Scholar 

  • Legendre CM, Licht C, et al. Terminal complement inhibitor eculizumab in atypical hemolytic-uremic syndrome. N Engl J Med 2013;368:2169–2181.

    Google Scholar 

  • Levi M, Toh CH, et al. Guidelines for the diagnosis and management of disseminated intravascular coagulation. British Committee for Standards in Haematology. Br J Haematol. 2009;145(1):24–33.

    Article  CAS  PubMed  Google Scholar 

  • Ling HT, Field JJ, et al. Sustained response with rituximab in patients with thrombotic thrombocytopenic purpura: a report of 13 cases and review of the literature. Am J Hematol. 2009;84(7):418–21.

    Article  CAS  PubMed  Google Scholar 

  • Lo GK, Juhl D, et al. Evaluation of pretest clinical score (4 T’s) for the diagnosis of heparin-induced thrombocytopenia in two clinical settings. J Thromb Haemost. 2006;4(4):759–65.

    Article  CAS  PubMed  Google Scholar 

  • Mader R, Ziporen L, et al. Antiphospholipid antibodies in a heterogeneous group of patients: experience from a central laboratory. Clin Rheumatol. 2002;21(5):386–90.

    Article  CAS  PubMed  Google Scholar 

  • Martin Jr JN, Bailey AP, et al. Thrombotic thrombocytopenic purpura in 166 pregnancies: 1955–2006. Am J Obstet Gynecol. 2008;199(2):98–104.

    Article  PubMed  Google Scholar 

  • McCrae KR. Thrombocytopenia in pregnancy: differential diagnosis, pathogenesis, and management. Blood Rev. 2003;17(1):7–14.

    Article  PubMed  Google Scholar 

  • McCrae KR. Thrombocytopenia in pregnancy. Hematology Am Soc Hematol Educ Program. 2010;2010:397–402.

    Article  PubMed  Google Scholar 

  • McCrae K. Immune thrombocytopenia: no longer ‘idiopathic’. Cleve Clin J Med. 2011;78(6):358–73.

    Article  PubMed  PubMed Central  Google Scholar 

  • McCrae KR, Samuels P, et al. Pregnancy-associated thrombocytopenia: pathogenesis and management. Blood. 1992;80(11):2697–714.

    CAS  PubMed  Google Scholar 

  • Michael M, Elliott EJ, et al. Interventions for hemolytic uremic syndrome and thrombotic thrombocytopenic purpura: a systematic review of randomized controlled trials. Am J Kidney Dis. 2009;53(2):259–72.

    Article  PubMed  Google Scholar 

  • Miller MH, Urowitz MB, et al. The significance of thrombocytopenia in systemic lupus erythematosus. Arthritis Rheum. 1983;26(10):1181–6.

    Article  CAS  PubMed  Google Scholar 

  • Murphy MF, Bussel JB. Advances in the management of alloimmune thrombocytopenia. Br J Haematol. 2007; 136(3):366–78.

    Article  PubMed  Google Scholar 

  • Neunert C, Lim W, et al. The American Society of Hematology 2011 evidence-based practice guideline for immune thrombocytopenia. Blood. 2011; 117(16):4190–207.

    Article  CAS  PubMed  Google Scholar 

  • Nguyen TC, Han YY. Plasma exchange therapy for thrombotic microangiopathies. Organogenesis. 2011;7(1):28–31.

    Article  PubMed  PubMed Central  Google Scholar 

  • Nguyen L, Reese J, et al. Drug-induced thrombocytopenia: an updated systematic review, 2010. Drug Saf. 2011;34(5):437–8.

    Article  PubMed  Google Scholar 

  • Nurden AT, Federici AB, et al. Altered megakaryocytopoiesis in von Willebrand type 2B disease. J Thromb Haemost. 2009;7 Suppl 1:277–81.

    Google Scholar 

  • Onder O, Weinstein A, et al. Pseudothrombocytopenia caused by platelet agglutinins that are reactive in blood anticoagulated with chelating agents. Blood. 1980;56(2):177–82.

    CAS  PubMed  Google Scholar 

  • Othman M. Platelet-type von Willebrand disease: a rare, often misdiagnosed and underdiagnosed bleeding disorder. Semin Thromb Hemost. 2011;37(5):464–9.

    Article  CAS  PubMed  Google Scholar 

  • Peyvandi F, Palla R, et al. ADAMTS-13 assays in thrombotic thrombocytopenic purpura. J Thromb Haemost. 2010;8(4):631–40.

    Article  CAS  PubMed  Google Scholar 

  • Provan D. Characteristics of immune thrombocytopenic purpura: a guide for clinical practice. Eur J Haematol Suppl. 2009;71:8–12.

    Article  PubMed  Google Scholar 

  • Provan D, Stasi R, et al. International consensus report on the investigation and management of primary immune thrombocytopenia. Blood. 2010;115(2):168–86.

    Article  CAS  PubMed  Google Scholar 

  • Rizvi MA, Shah SR, et al. Drug-induced thrombocytopenia. Curr Opin Hematol. 1999;6(5):349–53.

    Article  CAS  PubMed  Google Scholar 

  • Rock G. Plasma exchange in the management of thrombotic thrombocytopenic purpura. Vox Sang. 2002;83 Suppl 1:141–3.

    Google Scholar 

  • Sadler JE. New concepts in von Willebrand disease. Annu Rev Med. 2005;56:173–91.

    Article  CAS  PubMed  Google Scholar 

  • Sadler JE. Von Willebrand factor, ADAMTS13, and thrombotic thrombocytopenic purpura. Blood. 2008;112(1):11–8.

    Article  CAS  PubMed  Google Scholar 

  • Schiavotto C, Ruggeri M, et al. Adverse reactions after high-dose intravenous immunoglobulin: incidence in 83 patients treated for idiopathic thrombocytopenic purpura (ITP) and review of the literature. Haematologica. 1993;78(6 Suppl 2):35–40.

    CAS  PubMed  Google Scholar 

  • Stasi R, Amadori S, et al. Long-term outcome of otherwise healthy individuals with incidentally discovered borderline thrombocytopenia. PLoS Med. 2006;3(3):e24.

    Article  PubMed  PubMed Central  Google Scholar 

  • Taylor Jr FB, Toh CH, et al. Towards definition, clinical and laboratory criteria, and a scoring system for disseminated intravascular coagulation. Thromb Haemost. 2001;86(5):1327–30.

    CAS  PubMed  Google Scholar 

  • van Veen JJ, Nokes TJ, et al. The risk of spinal haematoma following neuraxial anaesthesia or lumbar puncture in thrombocytopenic individuals. Br J Haematol. 2010;148(1):15–25.

    Article  PubMed  Google Scholar 

  • Veneri D, Franchini M, et al. Thrombocytopenias: a clinical point of view. Blood Transfus. 2009;7(2):75–85.

    PubMed  PubMed Central  Google Scholar 

  • Warkentin TE. How I, diagnose and manage HIT. Hematology Am Soc Hematol Educ Program. 2011;2011:143–9.

    Article  PubMed  Google Scholar 

  • Warkentin TE, Kelton JG. A 14-year study of heparin-induced thrombocytopenia. Am J Med. 1996;101(5):502–7.

    Article  CAS  PubMed  Google Scholar 

  • Wong EY, Rose MG. Why does my patient have thrombocytopenia? Hematol Oncol Clin North Am. 2012;26(2):231–52. vii.

    Article  PubMed  Google Scholar 

  • Zheng X, Majerus EM, et al. ADAMTS13 and TTP. Curr Opin Hematol. 2002;9(5):389–94.

    Article  PubMed  Google Scholar 

  • Zimring JC, Welniak L, et al. Current problems and future directions of transfusion-induced alloimmunization: summary of an NHLBI working group. Transfusion. 2011;51(2):435–41.

    Article  PubMed  Google Scholar 

Download references

Author information

Authors and Affiliations

  1. Department of Hematology and Oncology, University of South Florida & H. Lee Moffitt Cancer Center & Research Institute, 12902 Magnolia Drive, Tampa, FL, 33602, USA

    Samir M. Dalia M.D.

  2. Division of Evidence Based Medicine, Department of Internal Medicine, University of South Florida, 12901 Bruce B. Downs Boulevard, MDC02, Tampa, FL, 33612, USA

    Benjamin Djulbegovic M.D., Ph.D.

  3. Department of Hematology & Health Outcomes & Behavior, H. Lee Moffitt Cancer Center & Research Institute, USF Health Clinical Research, 12901 Bruce B. Downs Boulevard, MDC02, Tampa, FL, 33612, USA

    Benjamin Djulbegovic M.D., Ph.D.

Authors
  1. Samir M. Dalia M.D.
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. Benjamin Djulbegovic M.D., Ph.D.
    View author publications

    You can also search for this author in PubMed Google Scholar

Corresponding author

Correspondence to Benjamin Djulbegovic M.D., Ph.D. .

Editor information

Editors and Affiliations

  1. Hematologic Oncology and Blood Disorders, Cleveland Clinic, Cleveland, Ohio, USA

    Alan Lichtin

  2. Cardiovascular Medicine and Hematology, Cleveland Clinic, Cleveland, Ohio, USA

    John Bartholomew

Rights and permissions

Reprints and permissions

Copyright information

© 2014 Springer Science+Business Media New York

About this chapter

Cite this chapter

Dalia, S.M., Djulbegovic, B. (2014). Diagnosing Thrombocytopenia in the Clinic. In: Lichtin, A., Bartholomew, J. (eds) The Coagulation Consult. Springer, New York, NY. https://doi.org/10.1007/978-1-4614-9560-4_7

Download citation

  • DOI: https://doi.org/10.1007/978-1-4614-9560-4_7

  • Published:

  • Publisher Name: Springer, New York, NY

  • Print ISBN: 978-1-4614-9559-8

  • Online ISBN: 978-1-4614-9560-4

  • eBook Packages: MedicineMedicine (R0)

Publish with us

Policies and ethics

Search

Navigation